CD4 and type 2 diabetes mellitus: In the Maastricht Study, an observational prospective population-based cohort that is characterized by an oversample of patients with type 2 diabetes, higher absolute number of basophils, and higher percentage of CD4 + T cells were cross-sectionally associated with a reduced NCV, whereas CD8 + T cell percentage pointed to the opposite.